National Kidney Foundation 2024 Spring Clinical Meeting Late-Breaking Abstracts May 14-18, 2024
W Gong1, U Diva1, M Bensink1, X Chai2, Y Xie2, S Gao2, B Hendry1, A Mercer3, Z-Y Zhou2, B Rovin4, J Barratt5. 1Travere Therapeutics, Inc, San Diego, CA, United States; 2Analysis Group, Boston, MA, United States; 3JAMCO Pharma Consulting, Stockholm, Sweden; 4Ohio State University, Wexner Medical Center, Columbus, OH, United States; 5University of Leicester, Leicester General Hospital, Leicester, United Kingdom